|
Male sex, (%)
|
78.7
|
69.7
|
1.60 (0.64–4.05)
|
0.315
|
|
Age, median (range)
|
62 (15–89)
|
55 (18–89)
|
–
|
0.360
|
|
Comorbidities, (%)
| | | | |
|
Pneumonia
|
58.7
|
60.6
|
0.92 (0.40–2.13)
|
0.850
|
|
Diabetes
|
17.3
|
6.1
|
3.25 (0.69–15.31)
|
0.208
|
|
Liver cirrhosis
|
4.0
|
6.1
|
0.65 (0.10–4.06)
|
1.000
|
|
Malignant tumor
|
12.0
|
12.1
|
0.99 (0.28–3.47)
|
1.000
|
|
Trauma
|
16.0
|
24.2
|
0.60 (0.22–1.63)
|
0.310
|
|
ICU stay, (%)
|
86.7
|
42.4
|
8.82 (3.38–23.02)
|
< 0.001
|
|
Inpatient days, median (range)
|
25 (6–155)
|
35 (12–163)
|
–
|
0.007
|
|
Deep vein intubation, (%)
|
89.3
|
78.8
|
2.25 (0.74–6.85)
|
0.247
|
|
Mechanical ventilation, (%)
|
81.3
|
60.0
|
2.49 (1.00–6.22)
|
0.048
|
|
Polymicrobial infection, (%)
| | | | |
|
Fungi
|
12.0
|
15.6
|
0.76 (0.24–2.48)
|
0.890
|
|
Other bacteria
|
46.7
|
51.5
|
0.82 (0.36–1.87)
|
0.642
|
|
A.baumannii isolated from other sites during hospital stay, (%)
| | | | |
|
Sputum
|
80.0
|
78.8
|
1.08 (0.39–2.95)
|
0.885
|
|
Cerebrospinal fluid
|
4.0
|
3.0
|
1.33 (0.13–13.31)
|
1.000
|
|
Usage of antibiotic, mean (range), (%)
| | | | |
|
Number of antibiotic classes used
|
3.16 (1–6)
|
3.52 (1–5)
|
–
|
0.162
|
|
Empirical antimicrobial therapy before isolating from blood
|
100
|
100
|
–
|
–
|
|
Change antimicrobial within 48 h after isolating from blood
|
53.3
|
87.9
|
0.16 (0.05–0.49)
|
< 0.001
|
|
Combination therapy
|
36.0
|
54.5
|
0.41 (0.18–0.96)
|
0.037
|
|
Laboratory examination, mean ± SD, (%)
| | | | |
|
White blood cell count (× 109/L)
|
13.2 ± 9.70
|
16.0 ± 11.0
|
–
|
0.208
|
|
Leukopenia (< 4 × 109/L)
|
18.7
|
6.1
|
3.56 (0.76–16.65)
|
0.160
|
|
Hemoglobin (g/L)
|
90.5 ± 21.4
|
94.7 ± 19.3
|
–
|
0.328
|
|
Anemia (< 100 g/L)
|
69.3
|
60.6
|
1.47 (0.63–3.45)
|
0.375
|
|
Platelet count (× 109/L)
|
123.1 ± 106.7
|
201.7 ± 104.0
|
–
|
< 0.001
|
|
Thrombocytopenia (< 50 × 109/L)
|
36.0
|
6.1
|
8.72 (1.93–39.30)
|
< 0.001
|
